Cargando…
Neuronal cell‐based medicines from pluripotent stem cells: Development, production, and preclinical assessment
Brain degeneration and damage is difficult to cure due to the limited endogenous repair capability of the central nervous system. Furthermore, drug development for treatment of diseases of the central nervous system remains a major challenge. However, it now appears that using human pluripotent stem...
Autores principales: | Sun, Yun, Feng, Lin, Liang, Lingmin, Stacey, Glyn N., Wang, Chaoqun, Wang, Yukai, Hu, Baoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560198/ https://www.ncbi.nlm.nih.gov/pubmed/34724724 http://dx.doi.org/10.1002/sctm.20-0522 |
Ejemplares similares
-
Toward Precision Medicine with Human Pluripotent Stem Cells for Diabetes
por: Memon, Bushra, et al.
Publicado: (2022) -
Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells
por: Wang, Li‐Tzu, et al.
Publicado: (2021) -
Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine
por: Poetsch, Mareike S, et al.
Publicado: (2022) -
Modeling aortic diseases using induced pluripotent stem cells
por: Zhu, Kai, et al.
Publicado: (2020) -
Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development
por: Stacey, Glyn N., et al.
Publicado: (2022)